Clinical Trial Update: Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) [Phase 4]

View source ↗

Summary

A Phase 4 study from Johns Hopkins evaluated whether roflumilast or azithromycin can prevent exacerbations in people with chronic obstructive pulmonary disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Azithromycin (azithromycin)
• Roflumilast (roflumilast)

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis | Phase 4 | Status: COMPLETED